Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Spirulina wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
12 of 13 studies with measurable effects showed benefit.
Top outcomes
300–500 mg daily
Morning with breakfast, Split dosing (morning and midday) for doses above 500 mg
Nicotinamide Riboside Chloride capsules or powder
3-10g daily
With food to mask taste, Morning for energy, Before meals for appetite effects
Powder or tablets
1–2 weeks
4–8 weeks
8–16 weeks
4–8 weeks
8-12 weeks
4-8 weeks
2-4 weeks
Immediate
The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.
Journal of cachexia, sarcopenia and muscle (2025) · Meta analysis
Systematic review and meta-analysis of RCTs evaluating NMN and NR effects on skeletal muscle mass and function
NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.
Ageing research reviews (2026) · Systematic review
PRISMA-guided systematic review of both preclinical and clinical NAD+ supplementation literature
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
Experimental gerontology (2020) · Systematic review
Systematic review of 147 articles (113 preclinical, 34 clinical) on NAD+ precursor therapy
Systematic Review of the Effects of Plant-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities Such as Obesity, Metabolic Syndrome, and Type 2 Diabetes
Nutrients (2025) · Systematic review
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become one of the most prevalent liver diseases, affecting up to 40% of adults and strongly associated with obesity and metabolic dysfunction.
The Role of Chlorella and Spirulina as Adjuvants of Cardiovascular Risk Factor Control: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Nutrients (2025) · Meta analysis · n=12
On the other hand, Spirulina intake led to a significant reduction in diastolic BP (-0.42, 95% CI: -0.81 to -0.02, p = 0.04) but did not significantly affect lipemia indexes, despite a trend toward a reduction in total cholesterol (-0.17, 95% CI: -0.39 to 0.06, p = 0.15).
Edible Algae Reduce Blood Pressure in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association (2025) · Meta analysis · n=1583
Edible algae intake significantly reduced systolic BP (SBP: -2.05 mmHg; 95% CI: -3.80, -0.31; p = 0.022) and diastolic BP (DBP: -1.87 mmHg; 95% CI: -3.10, -0.64; p = 0.001).
Based on 8-week RCT showing dose-dependent increases of 22%, 51%, and 142% at 100, 300, and 1000mg respectively. Individual response varies significantly (30% show variable response). NR-SAFE trial confirmed safety up to 2000mg.
Based on multiple meta-analyses showing dose-dependent effects. LDL reduction of ~33mg/dL and triglycerides ~39mg/dL reported. Effects appear to plateau above 8-10g daily.
AI-estimated from published studies. Interpret as directional guidance.
Spirulina has a higher evidence score (7/10 vs 5.5/10) and wins in 2 of 3 categories.
For healthy aging, Nicotinamide Riboside has a higher relevance score (90 vs 45).
No known interactions between Nicotinamide Riboside and Spirulina have been documented in our database. However, always consult a healthcare provider before combining supplements.